Original Article

Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization
  • Müge Çoban Karataş
  • Gürsel Yılmaz
  • Aslıhan Yüce Sezen
  • Çağla Sarıtürk
Turk J Ophthalmol 2022; 52: 45-49 DOI: 10.4274/tjo.galenos.2021.75608 PMID:35196839
Full
Text
Relationship Between Final Visual Acuity and Optical Coherence Tomography Findings in Patients with Diabetic Macular Edema Undergoing Anti-VEGF Therapy
  • Seher Eraslan
  • Özlem Yıldırım
  • Özer Dursun
  • Erdem Dinç
  • Gülhan Orekici Temel
Turk J Ophthalmol 2020; 50: 163-168 DOI: 10.4274/tjo.galenos.2019.91962 PMID:32631004
Full
Text
Real-World Outcomes of Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration in Turkey: A Multicenter Retrospective Study, Bosphorus Retina Study Group Report No: 1
  • Abdullah Özkaya
  • Levent Karabaş
  • Cengiz Alagöz
  • Zeynep Alkın
  • Özgür Artunay
  • Selim Bölükbaşı
  • Gökhan Demir
  • Mehmet Demir
  • Ali Demircan
  • Burak Erden
  • Gürkan Erdoğan
  • Mehmet Erdoğan
  • Erdem Eriş
  • Havva Kaldırım
  • İsmail Umut Onur
  • Özen Osmanbaşoğlu
  • Sezin Özdoğan Erkul
  • Mine Öztürk
  • İrfan Perente
  • Kübra Sarıcı
  • Nihat Sayın
  • Dilek Yaşa
  • İhsan Yılmaz
  • Zeynep Yılmazabdurrahmanoğlu
Turk J Ophthalmol 2018; 48: 232-237 DOI: 10.4274/tjo.31697 PMID:30405944
Full
Text
Prevalence of Polypoidal Choroidal Vasculopathy in Eyes with Neovascular Age-Related Macular Degeneration Resistant to Intravitreal Anti-VEGF Treatment
  • Jale Menteş
  • Mine Esen Barış
Turk J Ophthalmol 2022; 52: 338-341 DOI: 10.4274/tjo.galenos.2021.16578 PMID:36317811
Full
Text
Advanced Search

About Journal

Article Tools

Forms

Society

Useful Links

Subscribe
Pubmed Central
Scopus
Latest Update: 19.04.2024
2024 © Galenos Publishing House.